• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有丝分裂原诱导基因-6 是肝细胞和人肝癌细胞中表皮生长因子受体信号的负调节剂。

Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma.

机构信息

Max-Planck Institute of Biochemistry, Department of Molecular Biology, Martinsried, Germany.

出版信息

Hepatology. 2010 Apr;51(4):1383-90. doi: 10.1002/hep.23428.

DOI:10.1002/hep.23428
PMID:20044804
Abstract

UNLABELLED

The mitogen-inducible gene-6 (mig-6) is a multi-adaptor protein implicated in the regulation of the HER family of receptor tyrosine kinases. We have reported recently that mig-6 is a negative regulator of epidermal growth factor receptor (EGFR)-dependent skin morphogenesis and tumor formation in vivo. In the liver, ablation of mig-6 leads to an increase in EGFR protein levels, suggesting that mig-6 is a negative regulator of EGFR function. In line with this observation, primary hepatocytes isolated from mig-6 knockout and wild-type control mice display sustained mitogenic signaling in response to EGF. In order to explore the role of mig-6 in the liver in vivo, we analyzed liver regeneration in mig-6 knockout and wild-type control mice. Interestingly, mig-6 knockout mice display enhanced hepatocyte proliferation in the initial phases after partial hepatectomy. This phenotype correlates with activation of endogenous EGFR signaling, predominantly through the protein kinase B pathway. In addition, mig-6 is an endogenous inhibitor of EGFR signaling and EGF-induced tumor cell migration in human liver cancer cell lines. Moreover, mig-6 is down-regulated in human hepatocellular carcinoma and this correlates with increased EGFR expression.

CONCLUSION

Our data implicate mig-6 as a regulator of EGFR activity in hepatocytes and as a suppressor of EGFR signaling in human liver cancer.

摘要

未标记

有丝分裂原诱导基因 6(mig-6)是一种多接头蛋白,参与调节表皮生长因子受体(HER)家族的受体酪氨酸激酶。我们最近报道 mig-6 是表皮生长因子受体(EGFR)依赖性皮肤形态发生和体内肿瘤形成的负调节剂。在肝脏中,mig-6 的缺失会导致 EGFR 蛋白水平增加,这表明 mig-6 是 EGFR 功能的负调节剂。与这一观察结果一致,从 mig-6 敲除和野生型对照小鼠分离的原代肝细胞对 EGF 的反应显示持续的有丝分裂信号。为了探讨 mig-6 在体内肝脏中的作用,我们分析了 mig-6 敲除和野生型对照小鼠的肝再生。有趣的是,mig-6 敲除小鼠在部分肝切除后的初始阶段显示出增强的肝细胞增殖。这种表型与内源性 EGFR 信号的激活相关,主要通过蛋白激酶 B 途径。此外,mig-6 是人类肝癌细胞系中 EGFR 信号和 EGF 诱导的肿瘤细胞迁移的内源性抑制剂。此外,mig-6 在人肝癌中下调,这与 EGFR 表达增加相关。

结论

我们的数据表明 mig-6 是肝细胞中 EGFR 活性的调节剂,也是人肝癌中 EGFR 信号的抑制剂。

相似文献

1
Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma.有丝分裂原诱导基因-6 是肝细胞和人肝癌细胞中表皮生长因子受体信号的负调节剂。
Hepatology. 2010 Apr;51(4):1383-90. doi: 10.1002/hep.23428.
2
Evidence that MIG-6 is a tumor-suppressor gene.MIG-6是一种肿瘤抑制基因的证据。
Oncogene. 2007 Jan 11;26(2):269-76. doi: 10.1038/sj.onc.1209790. Epub 2006 Jul 3.
3
Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity.甲状腺特异性敲除抑癌基因丝裂原诱导基因 6 可激活表皮生长因子受体信号通路并抑制核因子-κB 活性。
Surgery. 2011 Dec;150(6):1295-302. doi: 10.1016/j.surg.2011.09.014.
4
Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation.Mig6是表皮生长因子受体介导的皮肤形态发生和肿瘤形成的负调控因子。
Nat Med. 2006 May;12(5):568-73. doi: 10.1038/nm1401. Epub 2006 Apr 30.
5
Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer.有丝分裂原诱导基因 6 是一种多功能衔接蛋白,在甲状腺乳头状癌中具有肿瘤抑制样活性。
J Clin Endocrinol Metab. 2011 Mar;96(3):E554-65. doi: 10.1210/jc.2010-1800. Epub 2010 Dec 29.
6
MicroRNA-374a Promotes Hepatocellular Carcinoma Cell Proliferation by Targeting Mitogen-Inducible Gene 6 (MIG-6).miR-374a 通过靶向丝裂原诱导基因 6(MIG-6)促进肝癌细胞增殖。
Oncol Res. 2018 May 7;26(4):557-563. doi: 10.3727/096504017X15000784459799. Epub 2017 Jul 21.
7
Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation.丝裂原诱导基因-6介导突变型BRAF对表皮生长因子受体的反馈抑制,从而限制恶性转化。
PLoS One. 2015 Jun 12;10(6):e0129859. doi: 10.1371/journal.pone.0129859. eCollection 2015.
8
Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis.Mig-6是正常肺发育和确保成年肺内环境稳定所必需的。
Development. 2009 Oct;136(19):3347-56. doi: 10.1242/dev.032979. Epub 2009 Aug 26.
9
Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer cell lines.Mig-6通过抑制非小细胞肺癌细胞系中的EGFR/ERK途径克服吉非替尼耐药性。
Int J Clin Exp Pathol. 2014 Sep 15;7(10):7304-11. eCollection 2014.
10
CKAP4 inhibited growth and metastasis of hepatocellular carcinoma through regulating EGFR signaling.CKAP4通过调节表皮生长因子受体(EGFR)信号通路抑制肝细胞癌的生长和转移。
Tumour Biol. 2014 Aug;35(8):7999-8005. doi: 10.1007/s13277-014-2000-3. Epub 2014 May 18.

引用本文的文献

1
In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID.使用AirID对具有CRBN或VHL结合剂的异双功能分子进行细胞内邻近靶点验证的方法
Commun Biol. 2025 Aug 30;8(1):1323. doi: 10.1038/s42003-025-08761-x.
2
High MIG-6 expression promotes tumor proliferation and metastasis of gastric cancer.高MIG-6表达促进胃癌的肿瘤增殖和转移。
J Cancer. 2025 Apr 21;16(8):2466-2475. doi: 10.7150/jca.98431. eCollection 2025.
3
Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor.
Mig6 突变可减少表皮生长因子受体的抑制。
FASEB J. 2024 Nov 30;38(22):e70194. doi: 10.1096/fj.202401330R.
4
Functional loss of ERBB receptor feedback inhibitor 1 (MIG6) promotes glioblastoma tumorigenesis by aberrant activation of epidermal growth factor receptor (EGFR).ERBB受体反馈抑制剂1(MIG6)的功能丧失通过表皮生长因子受体(EGFR)的异常激活促进胶质母细胞瘤的肿瘤发生。
Mol Oncol. 2025 Mar;19(3):937-953. doi: 10.1002/1878-0261.13717. Epub 2024 Aug 11.
5
ERRFI1 exacerbates hepatic ischemia reperfusion injury by promoting hepatocyte apoptosis and ferroptosis in a GRB2-dependent manner.ERRFI1 通过依赖于 GRB2 的方式促进肝细胞凋亡和铁死亡,从而加重肝缺血再灌注损伤。
Mol Med. 2024 Jun 11;30(1):82. doi: 10.1186/s10020-024-00837-4.
6
Precision oncology strategy in cetuximab-resistant ERRFI1-mutant colon cancer: case report of disease progression on afatinib.西妥昔单抗耐药的ERRFI1突变型结肠癌的精准肿瘤学策略:阿法替尼治疗疾病进展的病例报告
Am J Transl Res. 2023 Sep 15;15(9):5785-5790. eCollection 2023.
7
High-throughput functional screen identifies YWHAZ as a key regulator of pancreatic cancer metastasis.高通量功能筛选鉴定 YWHAZ 为胰腺癌转移的关键调节因子。
Cell Death Dis. 2023 Jul 14;14(7):431. doi: 10.1038/s41419-023-05951-5.
8
Prognostic Value of Erythroblastic Leukemia Viral Oncogene Homolog 2 and Neuregulin 4 in Hepatocellular Carcinoma.成红细胞白血病病毒癌基因同源物2和神经调节蛋白4在肝细胞癌中的预后价值
Cancers (Basel). 2023 May 6;15(9):2634. doi: 10.3390/cancers15092634.
9
Epigenome-wide analysis of aging effects on liver regeneration.衰老对肝脏再生影响的全基因组表观遗传学分析。
BMC Biol. 2023 Feb 13;21(1):30. doi: 10.1186/s12915-023-01533-1.
10
Androgen-Induced MIG6 Regulates Phosphorylation of Retinoblastoma Protein and AKT to Counteract Non-Genomic AR Signaling in Prostate Cancer Cells.雄激素诱导的 MIG6 通过调节视网膜母细胞瘤蛋白和 AKT 的磷酸化来拮抗前列腺癌细胞中的非基因组 AR 信号。
Biomolecules. 2022 Jul 29;12(8):1048. doi: 10.3390/biom12081048.